US Federal 2025-2026 Regular Session

US Federal House Bill HB5629

Introduced
9/30/25  

Caption

To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect.

Companion Bills

No companion bills found.

Previously Filed As

US AB1081

Modifying administrative rules relating to regulation of opioid treatment programs and requiring adjustments to the rates for substance use disorder treatment services with medications for opioid use disorder. (FE)

US SB1047

Modifying administrative rules relating to regulation of opioid treatment programs and requiring adjustments to the rates for substance use disorder treatment services with medications for opioid use disorder. (FE)

US SB5988

Establishing fee authority for accreditation services provided to opioid treatment programs by the department of health.

US HB2437

Establishing fee authority for accreditation services provided to opioid treatment programs by the department of health.

US SB2505

Relating To Opioid Use Disorder Treatment.

US H681

Update Opioid Abatement Treatment Prog. Rules

US HB2063

Relating To Opioid Use Disorder Treatment.

US H1379

Exempting medications used for the treatment of opioid use disorder from the prior approval process under the Massachusetts Medicaid program

US SB841

Opioid treatment programs; dispensing, medications from mobile units.

US H824

Expand Treatment Access/Opioid Use Disorder

Similar Bills

No similar bills found.